| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5325 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2771 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1669 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1337 | 2021 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 672 | 2021 |
| Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 492 | 2021 |
| Children are not COVID-19 super spreaders: time to go back to school APS Munro, SN Faust Archives of disease in childhood 105 (7), 618-619, 2020 | 286 | 2020 |
| Schools closures during the COVID-19 pandemic: a catastrophic global situation D Buonsenso, D Roland, C De Rose, P Vásquez-Hoyos, B Ramly, ... The Pediatric Infectious Disease Journal 40 (4), e146-e150, 2021 | 176 | 2021 |
| Pharmacological treatment of children with gastro‐oesophageal reflux M Tighe, NA Afzal, A Bevan, A Hayen, A Munro, RM Beattie Cochrane Database of Systematic Reviews, 2014 | 161 | 2014 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 138 | 2022 |
| Closing schools is not evidence based and harms children SJ Lewis, APS Munro, GD Smith, AM Pollock bmj 372, 2021 | 77 | 2021 |
| COVID-19 in children: current evidence and key questions APS Munro, SN Faust Current opinion in infectious diseases 33 (6), 540-547, 2020 | 68 | 2020 |
| Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of … X Liu, APS Munro, S Feng, L Janani, PK Aley, G Babbage, D Baxter, ... Journal of Infection 84 (6), 795-813, 2022 | 59 | 2022 |
| An evidence summary of Paediatric COVID-19 literature A Boast, A Munro, H Goldstein Don’t forget the Bubbles 382, 1663-1665, 2020 | 54* | 2020 |
| Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled … K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ... The Lancet Infectious Diseases 22 (12), 1703-1715, 2022 | 48 | 2022 |
| Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com … RH Shaw, X Liu, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet Respiratory Medicine 10 (11), 1049-1060, 2022 | 39 | 2022 |
| It’s time to put children and young people first during the global COVID-19 pandemic SN Faust, APS Munro JAMA pediatrics 175 (2), 127-128, 2021 | 38 | 2021 |
| Prevalence estimates and risk factors for early childhood wheeze across Europe: the EuroPrevall birth cohort A Selby, A Munro, KE Grimshaw, V Cornelius, T Keil, L Grabenhenrich, ... Thorax 73 (11), 1049-1061, 2018 | 34 | 2018 |
| Addendum to: Children are not COVID-19 super spreaders: Time to go back to school APS Munro, SN Faust Archives of Disease in Childhood 106 (2), e9-e9, 2021 | 31 | 2021 |
| Transmission of severe acute respiratory syndrome coronavirus 2 infection among children in summer schools applying stringent control measures in Barcelona, Spain I Jordan, M Fernandez de Sevilla, V Fumado, Q Bassat, E Bonet-Carne, ... Clinical Infectious Diseases 74 (1), 66-73, 2022 | 30* | 2022 |
Saul N. FaustProfessor of Paediatric Immunology & Infectious Diseases, University of SouthamptonGeverifieerd e-mailadres voor soton.ac.uk
